Cargando…

Chinese herbal medicines compared with N-acetylcysteine for the treatment of idiopathic pulmonary fibrosis: Protocol for a systematic review

BACKGROUND: Idiopathic pulmonary fibrosis (IPF) is a major public health problem worldwide. There is no curative treatment for IPF except lung transplantation. Chinese herbal medicines (CHMs) are widely used in the treatment of IPF in China. However, their effectiveness and safety are still obscure...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guo, Jing, Li, Bin, Li, Wenyuan, Pan, Yi, Wang, Zhichao, Wu, Yuxiao, Wang, Fei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6221552/ https://www.ncbi.nlm.nih.gov/pubmed/30383692 http://dx.doi.org/10.1097/MD.0000000000013077

Ejemplares similares

Chinese Herbal Medicines Compared with N-Acetylcysteine for the Treatment of Idiopathic Pulmonary Fibrosis: A Systematic Review of Randomized Controlled Trials
por: Guo, Jing, et al.
Publicado: (2019)

Efficacy and safety of N-acetylcysteine therapy for idiopathic pulmonary fibrosis: An updated systematic review and meta-analysis
por: Feng, Fanchao, et al.
Publicado: (2019)

Chinese herbal medicines for the treatment of cough in idiopathic pulmonary fibrosis: A protocol for systematic review and meta-analysis
por: Xiao, Siyao, et al.
Publicado: (2020)

Effects and mechanisms of pirfenidone, prednisone and acetylcysteine on pulmonary fibrosis in rat idiopathic pulmonary fibrosis models
por: Yu, Wencheng, et al.
Publicado: (2016)

Efficacy of N-Acetylcysteine in Idiopathic Pulmonary Fibrosis: A Systematic Review and Meta-Analysis
por: Sun, Tong, et al.
Publicado: (2016)

Pharmacological treatment of idiopathic pulmonary fibrosis – preclinical and clinical studies of pirfenidone, nintedanib, and N-acetylcysteine
por: Myllärniemi, Marjukka, et al.
Publicado: (2015)

Efficacy of N-acetylcysteine plus pirfenidone in the treatment of idiopathic pulmonary fibrosis: a systematic review and meta-analysis
por: Zhang, Xiu-Li, et al.
Publicado: (2023)

PHYTOPHOTODERMATITIS DUE TO CHINESE HERBAL MEDICINE DECOCTION
por: Zhang, Ruzhi, et al.
Publicado: (2011)

Efficacy and Safety of Traditional Chinese Medicine in Idiopathic Pulmonary Fibrosis: A Meta-Analysis
por: Ji, Kun, et al.
Publicado: (2020)

The Chinese Herbal Medicine Formula mKG Suppresses Pulmonary Fibrosis of Mice Induced by Bleomycin
por: Gao, Ying, et al.
Publicado: (2016)

The efficacy of Chinese herbal medicine as an adjunctive therapy for colorectal cancer: A protocol for systematic review of randomized controlled trials
por: Li, Wenyuan, et al.
Publicado: (2020)

N-acetylcysteine tiherapeutically protects against pulmonary fibrosis in a mouse model of silicosis
por: Huang, Huaping, et al.
Publicado: (2019)

Efficacy of N-acetylcysteine on idiopathic or postinfective non-cystic fibrosis bronchiectasis: a systematic review and meta-analysis protocol
por: Luo, Ai, et al.
Publicado: (2022)

Clinical efficacy of Chinese herbs for supplementing qi and activating blood circulation combined with N-acetylcysteine in the treatment of idiopathic pulmonary fibrosis: A systematic review and network meta-analysis
por: Pang, Qinglu, et al.
Publicado: (2022)

Different Chinese herbal medicine therapy for idiopathic thrombocytopenic purpura: A protocol for systematic review and Bayesian network meta-analysis
por: Chen, Wen-Ting, et al.
Publicado: (2021)

Multiple Traditional Chinese Medicine interventions for idiopathic pulmonary fibrosis: A protocol for systematic review and meta-analysis of overview
por: Zhang, Hao-Yang, et al.
Publicado: (2020)

538. The Role of N-acetylcysteine on Post Covid-19 Pulmonary Fibrosis
por: Demot, Bernard, et al.
Publicado: (2021)

Comparison of Pharmacokinetics and Anti-Pulmonary Fibrosis-Related Effects of Sulforaphane and Sulforaphane N-acetylcysteine
por: Son, Eun Suk, et al.
Publicado: (2021)

Research Progress of Chinese Herbal Medicine Intervention in Renal Interstitial Fibrosis
por: Liu, Xiao-Yuan, et al.
Publicado: (2022)

Comparison of Longevity in Patients with Idiopathic Pulmonary Fibrosis Using Pirfenidone Versus Triple Therapy with Prednisolone, Azathioprine, and Acetylcysteine
por: Asl, Mobin Soleimanian, et al.
Publicado: (2023)

Acupuncture for idiopathic pulmonary fibrosis: Protocol for a systematic review
por: Xie, Yang, et al.
Publicado: (2017)

N-Acetylcysteine attenuated pulmonary fibrosis induced by bleomycin via immunomodulation responses
por: Maghsadi, Zahra, et al.
Publicado: (2023)

Mechanisms of Chinese Herbal Medicines for Diabetic Nephropathy Fibrosis Treatment
por: Jiang, Tong, et al.
Publicado: (2022)

Efficacy and safety of traditional Chinese medicine in patients with acute exacerbation of idiopathic pulmonary fibrosis: study protocol for randomized, controlled, exploratory clinical trial
por: Hailong, Zhang, et al.
Publicado: (2022)

The future of the development of medicines in idiopathic pulmonary fibrosis
por: Fregonese, Laura, et al.
Publicado: (2015)

Precision medicine advances in idiopathic pulmonary fibrosis
por: Karampitsakos, Theodoros, et al.
Publicado: (2023)

Traditional Chinese medicine combined with pulmonary drug delivery system and idiopathic pulmonary fibrosis: Rationale and therapeutic potential
por: Zhang, Yukun, et al.
Publicado: (2021)

Chinese herbal medicine for psoriasis: Protocol for an overview of systematic reviews
por: Zhang, Jie, et al.
Publicado: (2020)

Curcumin induced oxidative stress attenuation by N-acetylcysteine co-treatment: a fibroblast and epithelial cell in-vitro study in idiopathic pulmonary fibrosis
por: Rodriguez, L. R., et al.
Publicado: (2019)

Establishment and application of the BRP prognosis model for idiopathic pulmonary fibrosis
por: Cheng, Xiaoyun, et al.
Publicado: (2023)

Comparative effectiveness of 3 Traditional Chinese Medicine treatment methods for idiopathic pulmonary fibrosis: A systematic review and network meta-analysis protocol
por: Pang, Li-Jian, et al.
Publicado: (2019)

Idiopathic Mesenteric Phlebosclerosis Secondary to Chinese Herbal Medicine Intake in an Older Adult
por: Kawashima, Akira, et al.
Publicado: (2023)

Promising therapeutic mechanism for Chinese herbal medicine in ameliorating renal fibrosis in diabetic nephropathy
por: Wang, Shengju, et al.
Publicado: (2023)

Safety of Chinese Herbal Medicine for Chronic Obstructive Pulmonary Disease
por: Coyle, Meaghan, et al.
Publicado: (2015)

External validation of the GAP model in Chinese patients with idiopathic pulmonary fibrosis
por: Zhang, Xinran, et al.
Publicado: (2022)

Effect of Chinese herbal medicine formula on progression-free survival among patients with metastatic colorectal cancer: Study protocol for a multi-center, double-blinded, randomized, placebo-controlled trial
por: Wang, Qiaoling, et al.
Publicado: (2022)

Traditional Chinese medicine for the treatment of pulmonary fibrosis: A protocol for systematic review and meta-analysis of overview
por: Li, Li-Juan, et al.
Publicado: (2020)

Real-World Effects of Chinese Herbal Medicine for Idiopathic Membranous Nephropathy (REACH-MN): Protocol of a Registry-Based Cohort Study
por: Yang, Lihong, et al.
Publicado: (2022)

Antiviral Strategies of Chinese Herbal Medicine Against PRRSV Infection
por: Bello-Onaghise, God’spower, et al.
Publicado: (2020)

Idiopathic mesenteric phlebosclerosis associated with use of Chinese herbal medicine: Two case reports
por: Wen, Yang, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_hmobidarqmpgp2efqo28vsg51e